Overseas Chinese Equities, Aequitas Research

Ming Lu

A veteran with 19-year experience in equity research.

Geographical coverage:
* Companies operating in China, but listed in Hong Kong and the U.S.
* Previously China A-share (listed in mainland China).

Equity sector coverage:
* Chinese App / Internet-based consumption in China, e.g., Alibaba, Tencent, etc.
* Previously covered education, transportation, telecom, power, bank, advertisement, hotel, etc.

Research methods:
* Generally bottom-up.
* Talk to related people on the ground.  Talk to readers and independent writers for analyzing a news portal.  Talk to parents and teachers for analyzing a tutoring school. 
* Visit stores and show photos as evidence in notes.
* Do technical analysis when finding a short-seller attacking an equity.

Languages:
* English
* Mandarin Chinese (Official language of China)
* Shanghainese (Language of Shanghai, the most developed city in China)
* Cantonese (Language of Hong Kong and Canton Province, one of the most developed provinces in China)

Overseas Chinese Equities

Pinduoduo (PDD): High-Performing Financials, But Low-Profile Management, 23% Downside

Pinduoduo (PDD): 4Q22, Lower Than Consensus, But Higher Than Competitors

Pinduoduo (PDD) Short Review: Third-Party Retailers “Bombarded” Direct Sales

Pinduoduo (PDD): 1Q22, Good Quarter, But Lockdown Scares Third-Party Retailers

Pinduoduo (PDD): 4Q21, Undervalued Growth Rate and Record Profit Since IPO, Buy

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>In 2Q22, revenue growth rate accelerated and the operating profit achieved record high.</li>
<li>However, we believe PDD does not fully explain its exclusive advantages over competitors.</li>
<li>We set a downside of 19% and a price target of US$47 for year end 2023.</li>
</ul>


In 2Q22, revenue growth rate accelerated and the operating profit achieved record high.
However, we believe PDD does not fully explain its exclusive advantages over competitors.
We set a downside of 19% and a price target of US$47 for year end 2023.


Pinduoduo (PDD): 2Q22, Viewpoint Opposite to Marvelous Performance

PDD Holdings

Pinduoduo (PDD): 2Q22, Viewpoint Opposite to Marvelous Performance